These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 7630628)

  • 1. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ; Paterson HF; Marshall CJ
    Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel, activated RAS mutations alter protein-protein interactions.
    Dalley BK; Cannon JF
    Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
    Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
    Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the sites of interaction between c-Raf-1 and Ras-GTP.
    Barnard D; Diaz B; Hettich L; Chuang E; Zhang XF; Avruch J; Marshall M
    Oncogene; 1995 Apr; 10(7):1283-90. PubMed ID: 7731678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
    Warne PH; Viciana PR; Downward J
    Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations that abolish the ability of Ha-Ras to associate with Raf-1.
    Shirouzu M; Koide H; Fujita-Yoshigaki J; Oshio H; Toyama Y; Yamasaki K; Fuhrman SA; Villafranca E; Kaziro Y; Yokoyama S
    Oncogene; 1994 Aug; 9(8):2153-7. PubMed ID: 8036000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf.
    Filchtinski D; Sharabi O; Rüppel A; Vetter IR; Herrmann C; Shifman JM
    J Mol Biol; 2010 Jun; 399(3):422-35. PubMed ID: 20361980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S; Bottorff D; Stone JC
    Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
    Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
    Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.
    Ehrhardt GR; Korherr C; Wieler JS; Knaus M; Schrader JW
    Oncogene; 2001 Jan; 20(2):188-97. PubMed ID: 11313946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
    Arai H; Escobedo JA
    Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor.
    Chen SY; Huff SY; Lai CC; Der CJ; Powers S
    Oncogene; 1994 Sep; 9(9):2691-8. PubMed ID: 8058333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential effects of the Gly-60 to Ala mutation on the interaction of H-Ras p21 with different downstream targets.
    Hwang MC; Sung YJ; Hwang YW
    J Biol Chem; 1996 Apr; 271(14):8196-202. PubMed ID: 8626511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.
    Clark GJ; Drugan JK; Terrell RS; Bradham C; Der CJ; Bell RM; Campbell S
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1577-81. PubMed ID: 8643674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAF protein-serine/threonine kinases: structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2010 Aug; 399(3):313-7. PubMed ID: 20674547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase.
    Moodie SA; Willumsen BM; Weber MJ; Wolfman A
    Science; 1993 Jun; 260(5114):1658-61. PubMed ID: 8503013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.